Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2008
12/04/2008WO2008147495A1 System and method for measuring fluid aeration
12/04/2008WO2008147426A2 Methods and compositions for immunomodulation
12/04/2008WO2008147418A1 Method of treating diseases with parp inhibitors
12/04/2008WO2008147382A1 Integrated microfluidic assay devices and methods
12/04/2008WO2008147345A2 System and method for antigen structure-independent detection of antigens captured on antibody arrays
12/04/2008WO2008147280A1 Method and device for determining the topography of a material surface
12/04/2008WO2008147206A2 Means and methods for classifying samples of multiple sclerosis patients
12/04/2008WO2008146911A1 Antibody directed against il13ra2, and diagnostic/therapeutic agent comprising the antibody
12/04/2008WO2008146903A1 Method for diagnosis of acute ischemic disease by utilizing activated hepcidin as measure
12/04/2008WO2008146854A1 Paratope and epitope of anti-mortalin antibody
12/04/2008WO2008146797A1 NOVEL GPIIIa GENE
12/04/2008WO2008146707A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof
12/04/2008WO2008146631A1 Non-specific adsorption inhibitor
12/04/2008WO2008146569A1 Biosensor
12/04/2008WO2008146474A1 Observation device
12/04/2008WO2008146276A1 System and method for analyzing fluids
12/04/2008WO2008146272A2 Compositions and methods for treating cxcr6/cxcl16 associated diseases
12/04/2008WO2008146259A2 Malt1 specific cleavage in assay and screening method
12/04/2008WO2008146100A1 Method for absolute quantification of polypeptides
12/04/2008WO2008145875A1 Fluorescent organic nanocrystals for producing biosensors
12/04/2008WO2008145785A1 Method for electrochemical detection of sequences of nucleic acids
12/04/2008WO2008145763A1 Method for absolute quantification of polypeptides
12/04/2008WO2008145722A1 Device and process for binding assays
12/04/2008WO2008145701A1 Method for predicting the outcome of a critically ill patient
12/04/2008WO2008145689A1 H-fabp as early predictor of myocardial infarction
12/04/2008WO2008145606A1 New mutational profile in hiv-1 gag cleavage site correlated with phenotypic drug resistance
12/04/2008WO2008145449A1 Method and device for measuring the composition of fibrous suspensions
12/04/2008WO2008145401A2 Mutated parvovirus structural proteins as vaccines
12/04/2008WO2008145384A1 Inflammation and oxidative stress level assay
12/04/2008WO2008145383A1 Immunological method, test kit and device for the determination of the analyte content of a sample
12/04/2008WO2008145130A1 Bio surface acoustic wave (saw) resonator amplification with nanoparticles for detection of a target analyte
12/04/2008WO2008145084A2 Method and immune absorbents for the specific detection and absorption of celiac disease- and herpetiform dermatitis-associated antibodies
12/04/2008WO2008145080A1 Optical measurement method for determining the ph of a medium using ageladine a as a fluorescent ph indicator
12/04/2008WO2008144933A1 Cinnamoyl inhibitors of transglutaminase
12/04/2008WO2008144891A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144890A1 Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
12/04/2008WO2008144850A1 Assay for determining risk of development of allergic disorders
12/04/2008WO2008144831A1 Method and apparatus for inspecting tissue
12/04/2008WO2008144817A1 Fluorescent protein particles
12/04/2008WO2008144808A1 Determining chemical oxygen demand in water samples
12/04/2008WO2008127718A3 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
12/04/2008WO2008127363A9 Devices for generating detectable polymers
12/04/2008WO2008122041A3 Biased ligands for receptors such as the pth receptor
12/04/2008WO2008120203A3 Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases
12/04/2008WO2008118970A9 Constructs and libraries comprising antibody surrogate light chain sequences
12/04/2008WO2008116468A3 Mhc peptide complexes and uses thereof in infectious diseases
12/04/2008WO2008116178A3 Systems and methods for diagnosis and prognosis of colorectal cancer
12/04/2008WO2008111916A8 Glycosphingolipid-aided intracellular delivery of cargo molecules
12/04/2008WO2008109414A3 Use of endogenous fluorescence to identify invading metastatic breast tumor cells
12/04/2008WO2008108877A3 Specific lysis of staphylococcal pathogens by bacteriophage phi1 1 endolysin
12/04/2008WO2008098106A9 Translational data mart
12/04/2008WO2008097582A3 Fluorescent single chain antibody (sc-fv) and its use in detection of analytes
12/04/2008WO2008094273A3 Detection of analytes in samples using liposome-amplified luminescence and magnetic separation
12/04/2008WO2008087478A3 Methods and apparatus for multi dimension fluorescence spectrum measurement and correlations downhole
12/04/2008WO2008084295A3 Method for measuring the physical-chemical parameters of natural gas
12/04/2008WO2008076365A3 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
12/04/2008WO2008073895A3 Methods and devices for testing saliva
12/04/2008WO2008073441A3 Compositions and methods for treating pathologic angiogenesis and vascular permeability
12/04/2008WO2008073157A9 Electrochemical biosensor arrays and systems and methods of making same
12/04/2008WO2008067042A3 Modeling wound healing
12/04/2008WO2008063821A3 Novel standard reference solutions
12/04/2008WO2008063663A3 Poly (ethylene glycol) anti-body detection assays and kits for performing thereof
12/04/2008WO2008063378A3 Haptens, hapten conjugates, compositions thereof and method for their preparation and use
12/04/2008WO2008062309A3 Anti-coronavirus molecules and their use in compositions and methods for treating and/or preventing infection caused by a coronavirus
12/04/2008WO2008060945A3 Diagnosis and treatment of breast cancer
12/04/2008WO2008057305A3 Assay for metastatic colorectal cancer
12/04/2008WO2008055703A3 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates
12/04/2008WO2008046029A3 Detectio n of specific binding reactions using magnetic labels
12/04/2008WO2008036121A3 Portable reactor for real-time nucleic acid amplification and detection
12/04/2008WO2008035343A3 Artificial receptors
12/04/2008WO2008028146A3 Novel protein compositions and systems for expression of desaturases
12/04/2008WO2008024862A3 Animal litter having the property of detecting diabetes in felines
12/04/2008WO2008024642A3 Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections
12/04/2008WO2008021493B1 A process for identification of molecular mimicry and the uses thereof
12/04/2008WO2008013986A3 Compositions and methods for treating or preventing ophthalmic light toxicity
12/04/2008WO2008013861A3 Screening assay for inhibitors of trpa1 activation by a lower alkyl phenol
12/04/2008WO2008005992A3 Dominant negative ligand drug discovery system
12/04/2008WO2008005810A3 System and methods for storing oxi datl vely-degradable foodstuff
12/04/2008WO2008005063A3 Enabling methods to identify allosteric modulators of receptor activity
12/04/2008WO2007149982A3 Diagnosis of autoimmune disease
12/04/2008WO2007139779A3 Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability
12/04/2008WO2007136781A3 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance
12/04/2008WO2007130677A3 Use of subcellular localization profiles as prognostic or predictive indicators
12/04/2008WO2007130403A3 REGULATION OF ApoB BY Hspl 10 PROTEINS AND RELATED COMPOSITIONS AND METHODS
12/04/2008WO2007127011A3 Apparatus and method for filtration to enhance the detection of peaks
12/04/2008WO2007126473A3 Oligomerization of amyloid proteins
12/04/2008WO2007121272A3 Methods and compositions involving nucleotide repeat disorders
12/04/2008WO2007110623A3 Screening method
12/04/2008WO2007103532A3 Normalizing cell assay data for models
12/04/2008WO2007100618A3 Novel cell-based phosphodiesterase assays
12/04/2008WO2007095527A3 Metal-enhanced chemiluminescence (mec)
12/04/2008WO2007094870A3 Toxicology and cellular effect of manufactured nanomaterials
12/04/2008WO2007062243A9 Serum-free expansion of cells in culture
12/04/2008WO2007025238A3 Use of fructose-based therapies for the treatment of cancer
12/04/2008WO2007002026A3 Identification of human t2r recepors that are activated by bitter molecules in coffee (chlorogenic lactones) and related assays for identifying human bitter taste modulators
12/04/2008WO2006088904A3 Fecal sample test device and methods of use
12/04/2008WO2005039388A3 Method for predicting the onset or change of a medical condition
12/04/2008WO2005020922A3 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
12/04/2008US20080301839 Transgenic plants with enhanced agronomic traits
12/04/2008US20080301824 Parkin interacting polypeptides and methods of use
1 ... 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 ... 3937